Emyria Limited (ASX: EMD) Webcast Replay
Emyria Limited (ASX: EMD) is a data-backed, drug development company. Emyria’s Treatments target unmet needs and are focused on obtaining approval from major global regulators.
As a part of our ‘The Insiders: Meet the CEOs’ series, CEO Dr Michael Winlo provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 17 February 2021 at 12pm (AEDT).